AID Cann

Company Overview

Snapshot

Founded in April 1993 by Nir Ben Zvi, Alexander Kozak, Dr., and Golan Bitton, AID Cann operates with 11–50 employees. The company has raised $37.65 million across 5 funding rounds from 11 investors. In December 2024, AID Cann was acquired by Limited 1498.

Business overview

AID Cann is a vertically integrated medical cannabis company that focuses on the cultivation, manufacture, distribution, and creation of medical cannabis products and dosage forms. The company holds initial licenses for the entire supply chain, including growing, breeding, nursery, production, research and development, and distribution. AID Cann produces its own cannabis through a partnership with Amit Farms, utilizing innovative agricultural technologies to develop strains for specific therapeutic needs. Its IMC-GMP certified manufacturing facility produces a wide variety of medical cannabis products meeting international standards, employing ethanol and CO2-based extraction technologies. The company operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis, serving the healthcare and life sciences industries.

Strategic signal

In December 2024, AID Cann was acquired by Limited 1498. This acquisition marks a significant exit for the company, indicating a successful culmination of its growth trajectory and strategic positioning within the medical cannabis market. For investors, this signals the potential for consolidation and value realization within the Health Tech & Life Sciences sector, particularly for vertically integrated medical cannabis firms.

Company Intelligence Q&A

What was a significant corporate milestone for AID Cann in December 2024?

In December 2024, AID Cann was acquired by Limited 1498, marking a significant corporate exit for the company.

What was a key investment event for AID Cann in July 2021?

In July 2021, Nir Tzuk invested 11.1 million shekels in AID Cann as part of a PIPE funding round, resulting in a 24% jump in AID Cann's stock on the Tel Aviv Stock Exchange.

What acquisition did AID Cann complete in June 2021?

In June 2021, AID Cann acquired Medipharm, a pharmacy, for $1.7 million as part of its strategy to control the medical cannabis production chain.

Who were the notable investors in AID Cann's funding round in July 2019?

In July 2019, AID Cann received investment from Ido Hagag and Chaim Hurvitz in a PIPE funding round.

What significant event occurred for AID Cann in September 2018?

In September 2018, AID Cann underwent a reverse merger event with D-Pharm, leading to its listing on the TASE.